Highlights

#UPDATE COVID-19:

#UPDATE COVID-19:

RCMO POST COVID -19 INFORMATION

Malaysia has entered the recovery phase of control movement order (RCMO) starting from 10th June 2020 till 31st August 2020 hoping to further bring down the infection figure. At the current stage, many restrictions have been loosened by the government to boost economic growth. In echo to the RCMO, UMMC higher management has released a circular (SP PPUM: 206/2020), all services will be fully operational, and no more rotation and work-from-home (WFH) systems will be implemented.

However, it may be considered in limited circumstances as required by the welfare of the staff as specified in the Public Service Department's Distribution Letter PSD (S) 256/6/31 JLD.6 (6) dated May 2, 2020. CIC staff will start working from the office fully from 15th June 2020 onwards.


Further details, please click on below file.
How to get Entry Visa: How-to-get-UMMC-Entry-Visa.pdf



Read More
#UPDATE COVID-19:

#UPDATE COVID-19:

Clinical Trials Factsheet on Covid-19 Worldwide by Dr. Phan Chia Wei, Head of CIC

Factsheet written by Dr Phan Chia Wei, Head of CIC, on clinical trials on COVID-19 worldwide. The factsheet is published by the Academy of Science Malaysia (ASM) in collaboration with the Young Scientists Network (YSN).

To add, we would like to express our heartiest congratulations to a new clinical trial in University Malaya Medical Centre, i.e. STORM (Strategizing TOcilizumab veRsus Methylprednisolone in COVID-19); with the ClinicalTrials.gov Identifier: NCT04345445. Hope all the best for the study!




Read More
#UPDATE COVID-19:

#UPDATE COVID-19:

UM leads clinical trials for Tocilizumab in Covid-19 treatment

Malaysia is embarking on a clinical study to evaluate the drug Tocilizumab for the treatment of severe cases of Covid-19.

Led by Universiti Malaya Faculty of Medicine dean Professor Datuk Dr Adeeba Kamarulzaman, the trial is underway at Universiti Malaya Medical Centre (UMMC), together with three public hospitals: Sungai Buloh Hospital, Kuala Lumpur Hospital and Tuanku Jaafar Hospital, Seremban.




Read More
#UPDATE COVID-19:

#UPDATE COVID-19:

UMMC, MOH  Hospitals Studying  Arthritis Drug Treatment for Severe Covid-19

Great news and new hope!

CIC and the UMMC Covid-19 special taskforce go full force looking for new treatment for Covid-19 patients.

"UMMC has already used tocilizumab (trade name Actemra) on several Covid-19 patients who developed "cytokine storm" syndrome, a dangerous overreaction of the immune system, resulting in respiratory and multi-organ failure and said that the results were encouraging".




Read More
#UPDATE COVID-19:

#UPDATE COVID-19:

Notice: Ward and Clinic Closure in University Malaya Mdical Centre

Notis: Penutupan Wad dan Klinik di Pusat Perubatan Universiti Malaya

Announcement:

UMMC is a COVID-19 hospital. The number of COVID-19 patients currently being treated in UMMC is increasing. However, Clinical Investigation Centre University Malaya Medical Centre will continue as usual until further notice. For more information, please contact us and our staff will assist you. ☎️ 03-7949 2260/2622/4907.

Pengumuman:

PPUM adalah hospital COVID-19. Bilangan pesakit COVID-19 yang sedang dirawat di PPUM semakin meningkat. Bagaimanapun, Bahagian Penyelidikan Klinikal Pusat Perubatan Universiti Malaya akan DITERUSKAN sehingga satu tempoh yang akan dimaklumkan kelak. Untuk maklumat lanjut, sila hubungi kami dan kakitangan kami akan membantu anda. ☎️ 03-7949 2260/ 2622 / 4907.




Read More
#UPDATE COVID-19:

#UPDATE COVID-19:

DERMA TABUNG COVID19 (UMMC)

PPUM melancarkan tabung bantuan untuk membantu pesakit COVID-19. Kepada yang ingin menyumbang boleh layari website yang tertera di poster. Bagi penyumbang selain dari tunai, boleh menghubungi Jabatan Kerja Sosial Perubatan PPUM:

1) Datin Rodhiah binti Zakaria - 013 3652302
2) Puah Khalidah binti Mustapa - 013 3402450
3) Pejabat Jabatan Kerja Sosial PPUM - 03-79492021

Terima kasih di atas sumbangan dan keprihatinan anda. 



Read More
#UPDATE COVID-19:

#UPDATE COVID-19:

COVID-19 SELF SCREENING

Do you need to go to the hospital for a COVID-19 examination?
Please answer the following questions to determine your risk for COVID-19 infection.  

Adakah anda perlu pergi ke hospital untuk membuat pemeriksaan COVID-19?
Sila jawab soalan-soalan berikut untuk mengetahui risiko anda menghidapi jangkitan COVID-19.



Read More
Events

Events

March Good Clinical Practice Workshop Postponed 

Dear participants, as all of you have already received an email and have made known about this, we, Cic Ummc unfortunately, have to postpone the March GCP workshop. The workshop will be resumed after the 30th of April or May. We will send you updates periodically.

We sincerely apologize for any inconveniences caused. We look forward to greeting you in the near future after we have seen through this current situation.

For further details, kindly email Ms. Hafizah (hanishafizah@ummc.edu.my) or Mdm. Hidayah (hiedayah@um.edu.my). 

Thank you.




Read More
News

News

New Cancer Treatment Machine in Clinical Investigation Centre

Clinical Investigation Centre has installed a new cancer treatment machine - REMISSION1°C.

What is REMISSION1°C?
It is a high frequency hyperthermia equipment. The working principle through application of high frequency electric energy into the body, the frictional heat is generated by the molecular movements such as their rotation, friction, twist, or collision.

What is the benifit of REMISSION1°C?
The heating processintended for relief of pain, inflammation and tissue healing. Unlike other electrical heating inducement, heat generated by Remission1°C from molecular movement as high frequency electricity passes through the molecules in the body without affecting sensory and motor nerves in the body, which usually caused muscular contraction or any discomfort.
 



Read More
RESEARCH

RESEARCH

Research Application Form
Registration of Clinical Research Under Clinical Investigation Centre (Response Form)



Read More
News

News

 Phase 1b Clinical Study for Hepatitis B at UMMC
Congratulations to Prof Dr. Rosmawati Mohamed & Study Team for the success.



Read More
News

News

Clinical Investigation Centre on BERNAMA
Assoc. Prof. Dr. Hasniza Bt. Zaman Huri on Biosimilar Bernama TV for the Biosimilar event at Nilai.



Read More
Liraglutide in Children and Adolescents with Type 2 Diabetes

Liraglutide in Children and Adolescents with Type 2 DiabetesThis article was written by Prof  Muhammad Yazid Jalaludin(Department of Paediatrics, UMMC) in cooperation with other Researchers for the Ellipse Trial Investigators.

Metformin is the regulatory-approved treatment of choice for most youth with type 2 diabetes early in the disease. However, early loss of glycemic control has been observed with metformin monotherapy. Whether liraglutide added to metformin (with or without basal insulin treatment) is safe and effective in youth with type 2 diabetes is unknown.




Read More
Tips & Trick

Tips & Trick

How To Start Clinical Trial?

Flowchart on how to conduct clinical trial through CIC




Read More
Facilities and Services

Facilities and Services

CIC provides facilities such as human resource, infrastructure and equipment for the conduct of clinical trials in UMMC.




Read More